LOS ANGELES: Pfizer and its German partner BioNTech said that preliminary clinical data shows their three-dose Covid-19 vaccine regimen is 80% effective for children aged from six months to five years old at preventing illness during the Omicron wave.
The vaccine was found to elicit a strong immune response following a third dose, and was well-tolerated by children with a majority showing mild to moderate side effects, according to the companies, reported Xinhua.
Join our Telegram channel to get our Evening Alerts and breaking news highlights
